Cadrenal Therapeutics, Common Stock Price Prediction
| CVKD Stock | 14.99 0.98 7.00% |
Oversold Vs Overbought
61
Oversold | Overbought |
EPS Estimate Next Quarter (2.03) | EPS Estimate Current Year (7.79) | EPS Estimate Next Year (4.27) | Wall Street Target Price 35.6667 | EPS Estimate Current Quarter (1.93) |
Using Cadrenal Therapeutics, hype-based prediction, you can estimate the value of Cadrenal Therapeutics, Common from the perspective of Cadrenal Therapeutics, response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Cadrenal Therapeutics, to buy its stock at a price that has no basis in reality. In that case, they are not buying Cadrenal because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Cadrenal Therapeutics, after-hype prediction price | USD 14.01 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Cadrenal |
Cadrenal Therapeutics, After-Hype Price Prediction Density Analysis
As far as predicting the price of Cadrenal Therapeutics, at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cadrenal Therapeutics, or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Cadrenal Therapeutics,, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Cadrenal Therapeutics, Estimiated After-Hype Price Volatility
In the context of predicting Cadrenal Therapeutics,'s stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cadrenal Therapeutics,'s historical news coverage. Cadrenal Therapeutics,'s after-hype downside and upside margins for the prediction period are 5.81 and 22.21, respectively. We have considered Cadrenal Therapeutics,'s daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Cadrenal Therapeutics, is moderately volatile at this time. Analysis and calculation of next after-hype price of Cadrenal Therapeutics, is based on 3 months time horizon.
Cadrenal Therapeutics, Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Cadrenal Therapeutics, is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cadrenal Therapeutics, backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cadrenal Therapeutics,, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.37 | 8.23 | 1.71 | 0.26 | 10 Events / Month | 15 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
14.99 | 14.01 | 0.00 |
|
Cadrenal Therapeutics, Hype Timeline
Cadrenal Therapeutics, is currently traded for 14.99. The entity has historical hype elasticity of 1.71, and average elasticity to hype of competition of -0.26. Cadrenal is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 1.37%. %. The volatility of related hype on Cadrenal Therapeutics, is about 4301.58%, with the expected price after the next announcement by competition of 14.73. About 34.0% of the company shares are held by company insiders. The company recorded a loss per share of 6.73. Cadrenal Therapeutics, had not issued any dividends in recent years. The entity had 1:15 split on the 20th of August 2024. Given the investment horizon of 90 days the next forecasted press release will be in about 10 days. Check out Cadrenal Therapeutics, Basic Forecasting Models to cross-verify your projections.Cadrenal Therapeutics, Related Hype Analysis
Having access to credible news sources related to Cadrenal Therapeutics,'s direct competition is more important than ever and may enhance your ability to predict Cadrenal Therapeutics,'s future price movements. Getting to know how Cadrenal Therapeutics,'s peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cadrenal Therapeutics, may potentially react to the hype associated with one of its peers.
Cadrenal Therapeutics, Additional Predictive Modules
Most predictive techniques to examine Cadrenal price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cadrenal using various technical indicators. When you analyze Cadrenal charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Cadrenal Therapeutics, Predictive Indicators
The successful prediction of Cadrenal Therapeutics, stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Cadrenal Therapeutics, Common, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Cadrenal Therapeutics, based on analysis of Cadrenal Therapeutics, hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Cadrenal Therapeutics,'s market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cadrenal Therapeutics,'s related companies.
Story Coverage note for Cadrenal Therapeutics,
The number of cover stories for Cadrenal Therapeutics, depends on current market conditions and Cadrenal Therapeutics,'s risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cadrenal Therapeutics, is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cadrenal Therapeutics,'s long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Cadrenal Therapeutics, Short Properties
Cadrenal Therapeutics,'s future price predictability will typically decrease when Cadrenal Therapeutics,'s long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cadrenal Therapeutics, Common often depends not only on the future outlook of the potential Cadrenal Therapeutics,'s investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cadrenal Therapeutics,'s indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 13.5 M | |
| Cash And Short Term Investments | 8.4 M |
Complementary Tools for Cadrenal Stock analysis
When running Cadrenal Therapeutics,'s price analysis, check to measure Cadrenal Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cadrenal Therapeutics, is operating at the current time. Most of Cadrenal Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Cadrenal Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cadrenal Therapeutics,'s price. Additionally, you may evaluate how the addition of Cadrenal Therapeutics, to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |